Loss of IGFBP2 Mediates Alveolar Type 2 Cell Senescence and Promotes Lung Fibrosis

Scientists reported that intranasal delivery of recombinant insulin-like growth factor binding proteins (IGFBP2) protects aged mice from weight loss and demonstrated antifibrotic effects after bleomycin lung injury.